Showing 1731-1740 of 8102 results for "".
The Literature
https://crstoday.com/topics/general/the-literature-6/42778/Measuring Visual Performance and Quality of Vision
https://crstoday.com/topics/general/measuring-visual-performance-and-quality-of-vision/42693/This information helps refractive surgeons optimize patients' outcomes.Letters
https://crstoday.com/topics/general/letters-7/42677/Lights, Camera, Action
https://crstoday.com/topics/general/lights-camera-action/42588/When physicians are in the spotlight, the show must go on, but patients come first.Elective Space: Seeking Innovation, Collaboration
https://crstoday.com/topics/general/elective-space-seeking-innovation-collaboration/42568/New private equity firm unites doctors in a novel approach to the aesthetics, vision, and other elective markets.Reducing Your Enhancement Rates
https://crstoday.com/topics/general/reducing-your-enhancement-rates/42423/This expert's proposed surgical framework will have you improving your outcomes in no time.Introducing New Technology With an Eye on Sustainability
https://crstoday.com/topics/general/introducing-new-technology-with-an-eye-on-sustainability-2/42415/A long-term study of a keratoprosthetic device in Ethiopia and Sudan has benefited patients and the technology.Introducing New Technology With an Eye on Sustainability
https://crstoday.com/topics/general/introducing-new-technology-with-an-eye-on-sustainability/42244/A long-term study of a keratoprosthetic device in Ethiopia and Sudan has benefited patients and the technology.From Mind to Market
https://crstoday.com/topics/general/from-mind-to-market/42150/How an industry's need for change inspired the future of aberrometry.Phase 2 Clinical Trial of NVC-422 for Adenoviral Conjunctivitis
https://crstoday.com/topics/general/phase-2-clinical-trial-of-nvc-422-for-adenoviral-conjunctivitis/42002/